Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) Research & Development (2016 - 2025)

Glaukos (GKOS) has disclosed Research & Development for 12 consecutive years, with $43.7 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 19.5% to $43.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $150.6 million through Dec 2025, up 10.4% year-over-year, with the annual reading at $150.6 million for FY2025, 10.4% up from the prior year.
  • Research & Development for Q4 2025 was $43.7 million at Glaukos, up from $38.1 million in the prior quarter.
  • The five-year high for Research & Development was $43.7 million in Q4 2025, with the low at $21.2 million in Q1 2021.
  • Average Research & Development over 5 years is $32.5 million, with a median of $33.3 million recorded in 2023.
  • Peak annual rise in Research & Development hit 42.07% in 2021, while the deepest fall reached 14.69% in 2021.
  • Over 5 years, Research & Development stood at $26.7 million in 2021, then skyrocketed by 34.24% to $35.8 million in 2022, then increased by 3.49% to $37.1 million in 2023, then decreased by 1.44% to $36.5 million in 2024, then increased by 19.5% to $43.7 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $43.7 million, $38.1 million, and $36.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.